奇正藏药
(002287)
| 流通市值：116.77亿 | | | 总市值：117.00亿 |
| 流通股本：5.71亿 | | | 总股本：5.72亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 977,970,271.25 | 405,252,640.82 | 2,416,012,277.2 | 1,522,943,818.43 |
| 营业总成本 | 634,798,072.31 | 315,927,892.39 | 1,850,672,675.76 | 1,201,047,151.05 |
| 其他经营收益 | | | | |
| 营业利润 | 416,459,579.66 | 109,080,025.17 | 768,624,790.5 | 491,866,116.07 |
| 利润总额 | 414,465,815.76 | 109,036,728.2 | 739,842,481.91 | 472,245,275.2 |
| 净利润 | 370,142,900.73 | 93,964,932.52 | 647,474,119.23 | 423,563,245.08 |
| 每股收益 | | | | |
| 其他综合收益 | -3,414,575.99 | -1,868,313.53 | -2,798,072 | -1,805,165.44 |
| 综合收益总额 | 366,728,324.74 | 92,096,618.99 | 644,676,047.23 | 421,758,079.64 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,962,858,961.18 | 4,066,912,817.27 | 4,308,167,787.31 | 4,056,960,926.68 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,766,355,442.95 | 2,590,107,399.83 | 2,608,099,972.5 | 2,581,385,013.03 |
| 资产总计 | 6,729,214,404.13 | 6,657,020,217.1 | 6,916,267,759.81 | 6,638,345,939.71 |
| 流动负债: | | | | |
| 流动负债合计 | 1,327,491,313.16 | 1,305,191,839.06 | 1,678,543,366.32 | 1,541,776,493.08 |
| 非流动负债: | | | | |
| 非流动负债合计 | 256,945,371.37 | 263,446,013.9 | 242,132,457.15 | 245,553,763.55 |
| 负债合计 | 1,584,436,684.53 | 1,568,637,852.96 | 1,920,675,823.47 | 1,787,330,256.63 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,097,941,422.16 | 5,041,628,004.49 | 4,947,659,807.97 | 4,802,010,022.6 |
| 股东权益合计 | 5,144,777,719.6 | 5,088,382,364.14 | 4,995,591,936.34 | 4,851,015,683.08 |
| 负债和股东权益合计 | 6,729,214,404.13 | 6,657,020,217.1 | 6,916,267,759.81 | 6,638,345,939.71 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,252,853,463.17 | 398,086,477.93 | 2,904,722,767.78 | 2,010,876,734.37 |
| 经营活动现金流出小计 | 1,013,374,520.11 | 561,563,872.89 | 2,175,020,072.5 | 1,508,337,991.18 |
| 经营活动产生的现金流量净额 | 239,478,943.06 | -163,477,394.96 | 729,702,695.28 | 502,538,743.19 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 657,149,801.35 | 432,537,740.23 | 1,511,974,304.33 | 1,278,087,380.07 |
| 投资活动现金流出小计 | 751,597,714.67 | 361,453,079.1 | 1,490,981,854.66 | 1,259,709,476.53 |
| 投资活动产生的现金流量净额 | -94,447,913.32 | 71,084,661.13 | 20,992,449.67 | 18,377,903.54 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 592,994,628.48 | 432,777,173.26 | 962,776,102 | 896,827,349.5 |
| 筹资活动现金流出小计 | 847,839,943.91 | 560,623,828.9 | 1,526,858,548.91 | 1,321,845,532.74 |
| 筹资活动产生的现金流量净额 | -254,845,315.43 | -127,846,655.64 | -564,082,446.91 | -425,018,183.24 |
| 汇率变动对现金及现金等价物的影响 | -356,342.95 | -107,573.47 | -112,417.16 | -1,805,712.9 |
| 现金及现金等价物净增加额 | -110,170,628.64 | -220,346,962.94 | 186,500,280.88 | 94,092,750.59 |
| 期末现金及现金等价物余额 | 265,921,145.74 | 155,744,811.44 | 376,091,774.38 | 283,684,244.09 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -110,170,628.64 | - | 186,500,280.88 | - |